HempFusion Drives CBD Retail Push Across
Influential State via Key Grocery Channel
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness Company offering premium probiotic supplements and
products containing CBD, is pleased to announce the launch of
HempFusion Ingestible and Topical CBD products into nearly 50
retail locations of a major Arizona grocer.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211028005255/en/
HempFusion CBD Products (Photo: Business
Wire)
According to Brightfield Group, the grocery channel will be the
fastest growing channel for CBD products between 2021 and 2026. In
2021, CBD sales in this channel are expected to grow to $165
million, up 151% from 2020, and forecast to reach $769 million in
2026.
With products already available across the state, Arizona
consumers have more than 20 HempFusion SKUs to choose from,
including USDA Organic Certified Tinctures, Sleep and Stress
Support Capsules, delicious Summer Cherry and Elderberry Gummies,
and a variety of best-in-class over-the-counter (OTC) Topicals. In
addition, four SKUs of HempFusion’s wholly-owned subsidiary, Sagely
Naturals, are on store shelves, including Relief & Recovery
Cream, Active Roll-On, and Extra Strength Spray.
“We continue to make great progress expanding our retail
footprint in order to capitalize on our strong brand portfolio and
growing consumer trends in the CBD category,” said Jason Mitchell,
N.D., HempFusion‘s Co-Founder and Chief Executive Officer. “Adding
this new key grocery retailer in a market like Arizona which
over-indexes on per-capita CBD consumption versus most other
states, helps us gain greater share in the state, and positions the
Company for future potential regulatory changes. Total store count
for our products across the US is climbing, now exceeding the
15,000 locations we had communicated previously, and we expect to
provide additional details about our brick & mortar progress
with the release of our third-quarter financial results scheduled
for mid-November,” continued Dr. Mitchell.
ABOUT HEMPFUSION
One of a select few CBD companies who are today fully prepared
to meet or exceed expected FDA guidance, HempFusion Wellness Inc.
is a leading health and wellness company whose family of premium
consumer brands include HempFusion™, Sagely Naturals™,
Apothecanna™, and Probulin Probiotics™, one of the fastest-growing
probiotics companies in the United States according to SPINs
reported data.
Utilizing the power of whole-food hemp nutrition, the HempFusion
family of brands’ product portfolio comprises 112 SKUs including
USDA Organic Certified Tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, probiotic supplements and skin
care products, a Doctor/Practitioner line, a White Label division
and more. With a strong focus on research and development,
HempFusion Wellness has 43 products under development.
Available from more than 15,000 US retail locations across all
50 states, HempFusion Wellness products are also available in
China, Mexico, Ireland, United Kingdom, United Arab Emirates, South
Korea and Canada and may be purchased online from each brand’s
website, The Probulin Store on Amazon.com, Alibaba’s Tmall.com, the
world’s largest cross-border online marketplace, and a multitude of
additional e-commerce sites.
For more information, visit www.hempfusion.com. Follow
HempFusion on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to
expansion of the Company’s retail footprint, potential regulatory
changes and the Company’s other plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211028005255/en/
Investor Relations: Eric Balshin +1 437-826-9911
eric@sophiccapital.com Company Contact: Jason Mitchell, N.D. Chief
Executive Officer and Director ir@hempfusion.com
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025
